BDBM536271 1-((2S,4R)-2-((R)-5-(2′-fluoro-[1,1′-biphenyl]-4-yl)-5-methyl-4,5-dihydro-1,2,4-oxadiazol-3-yl)-4-hydroxypyrrolidin-1-yl)-3-methyl-2-(3-methylisoxazol-5-yl)butan-1-one (2 Stereoisomers)::US11242344, Example 139.1
SMILES Cc1cc(C(C(=O)N2C[C@H](O[Si](C)(C)C(C)(C)C)C[C@H]2C2=NOC(C)(c3ccc(Br)cc3)N2)C(C)C)on1
InChI Key InChIKey=ZODMTQOCDYVPAH-UHFFFAOYSA-N
Data 2 IC50
Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB
Found 2 hits for monomerid = 536271
TargetElongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213](Human)
Genentech
US Patent
Genentech
US Patent
Affinity DataIC50: 1.00E+4nMAssay Description:The binding of test compounds to the VHL Elongin B/C complex was measured using a fluorescence polarization tracer competition assay. The VHL/Elongin...More data for this Ligand-Target Pair
Affinity DataIC50: 2.17E+4nMAssay Description:The VHL NanoBRET Target Engagement Assay analyzes the apparent affinity of test compounds for VHL in cells by competitive displacement of a VHL NanoB...More data for this Ligand-Target Pair
